DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,978,000 | +0.2% | 175,000 | +16.7% | 0.07% | -13.0% |
| Q2 2020 | $8,958,000 | -64.7% | 150,000 | -75.7% | 0.08% | -71.7% |
| Q1 2020 | $25,371,000 | -14.3% | 616,261 | +29.6% | 0.27% | +5.4% |
| Q4 2019 | $29,594,000 | +185.0% | 475,484 | +55.4% | 0.26% | +177.4% |
| Q3 2019 | $10,385,000 | -66.7% | 305,978 | -62.0% | 0.09% | -64.9% |
| Q3 2018 | $31,170,000 | +33.2% | 805,004 | +35.4% | 0.26% | +87.9% |
| Q2 2018 | $23,396,000 | +747.7% | 594,551 | +331.8% | 0.14% | +403.6% |
| Q1 2018 | $2,760,000 | -51.3% | 137,700 | -44.9% | 0.03% | -51.7% |
| Q4 2017 | $5,668,000 | – | 250,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |